190 related articles for article (PubMed ID: 20935520)
1. FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy.
Zhang N; Qi Y; Wadham C; Wang L; Warren A; Di W; Xia P
Autophagy; 2010 Nov; 6(8):1157-67. PubMed ID: 20935520
[TBL] [Abstract][Full Text] [Related]
2. Combination of FTY720 with cisplatin exhibits antagonistic effects in ovarian cancer cells: role of autophagy.
Zhang N; Dai L; Qi Y; Di W; Xia P
Int J Oncol; 2013 Jun; 42(6):2053-9. PubMed ID: 23592281
[TBL] [Abstract][Full Text] [Related]
3. FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells.
Wallington-Beddoe CT; Hewson J; Bradstock KF; Bendall LJ
Autophagy; 2011 Jul; 7(7):707-15. PubMed ID: 21460633
[TBL] [Abstract][Full Text] [Related]
4. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells.
Zhang L; Wang H; Ding K; Xu J
Toxicol Lett; 2015 Jul; 236(1):43-59. PubMed ID: 25939952
[TBL] [Abstract][Full Text] [Related]
5. FTY720-induced enhancement of autophagy protects cells from FTY720 cytotoxicity in colorectal cancer.
Li J; Wang SW; Zhang DS; Sun Y; Zhu CY; Fei Q; Hu J; Zhang C; Sun YM
Oncol Rep; 2016 May; 35(5):2833-42. PubMed ID: 26985637
[TBL] [Abstract][Full Text] [Related]
6. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
Li Y; Hu T; Chen T; Yang T; Ren H; Chen M
Oncol Rep; 2018 Feb; 39(2):565-572. PubMed ID: 29207165
[TBL] [Abstract][Full Text] [Related]
7. [Mechanisms of ROS in U266 cell death induced by FTY720].
Li YC; Liu ZG; Yao K; Wang HH; Hu R; Yang W; Liao AJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):643-6. PubMed ID: 23815914
[TBL] [Abstract][Full Text] [Related]
8. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression.
Ishitsuka A; Fujine E; Mizutani Y; Tawada C; Kanoh H; Banno Y; Seishima M
Int J Mol Med; 2014 Oct; 34(4):1169-74. PubMed ID: 25109763
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro.
Marvaso G; Barone A; Amodio N; Raimondi L; Agosti V; Altomare E; Scotti V; Lombardi A; Bianco R; Bianco C; Caraglia M; Tassone P; Tagliaferri P
Cancer Biol Ther; 2014 Jun; 15(6):797-805. PubMed ID: 24657936
[TBL] [Abstract][Full Text] [Related]
10. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.
Liu Q; Zhao X; Frissora F; Ma Y; Santhanam R; Jarjoura D; Lehman A; Perrotti D; Chen CS; Dalton JT; Muthusamy N; Byrd JC
Blood; 2008 Jan; 111(1):275-84. PubMed ID: 17761520
[TBL] [Abstract][Full Text] [Related]
11. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y
Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219
[TBL] [Abstract][Full Text] [Related]
12. FTY720-induced blockage of autophagy enhances anticancer efficacy of milatuzumab in mantle cell lymphoma: is FTY720 the next autophagy-blocking agent in lymphoma treatment?
Alinari L; Baiocchi RA; Praetorius-Ibba M
Autophagy; 2012 Mar; 8(3):416-7. PubMed ID: 22377620
[TBL] [Abstract][Full Text] [Related]
13. FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.
Alinari L; Mahoney E; Patton J; Zhang X; Huynh L; Earl CT; Mani R; Mao Y; Yu B; Quinion C; Towns WH; Chen CS; Goldenberg DM; Blum KA; Byrd JC; Muthusamy N; Praetorius-Ibba M; Baiocchi RA
Blood; 2011 Dec; 118(26):6893-903. PubMed ID: 22042694
[TBL] [Abstract][Full Text] [Related]
14. Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.
Nagaoka Y; Otsuki K; Fujita T; Uesato S
Biol Pharm Bull; 2008 Jun; 31(6):1177-81. PubMed ID: 18520051
[TBL] [Abstract][Full Text] [Related]
15. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.
Ntranos A; Hall O; Robinson DP; Grishkan IV; Schott JT; Tosi DM; Klein SL; Calabresi PA; Gocke AR
J Neuroimmunol; 2014 May; 270(1-2):13-21. PubMed ID: 24680062
[TBL] [Abstract][Full Text] [Related]
16. Autophagy induced by FTY720 promotes apoptosis in U266 cells.
Liao A; Hu R; Zhao Q; Li J; Li Y; Yao K; Zhang R; Wang H; Yang W; Liu Z
Eur J Pharm Sci; 2012 Apr; 45(5):600-5. PubMed ID: 22281442
[TBL] [Abstract][Full Text] [Related]
17. FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism.
Bai LY; Chiu CF; Chiu SJ; Chu PC; Weng JR
Sci Rep; 2017 Jul; 7(1):5600. PubMed ID: 28717222
[TBL] [Abstract][Full Text] [Related]
18. [The study of FTY720 on inducing apoptosis and autophagy in multiple myeloma cell line U266].
Liao AJ; Hu R; Li YC; Yao K; Wang HH; Zhang R; Yang W; Liu ZG
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):664-7. PubMed ID: 22339823
[TBL] [Abstract][Full Text] [Related]
19. FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
Li MH; Hla T; Ferrer F
Pediatr Blood Cancer; 2013 Sep; 60(9):1418-23. PubMed ID: 23704073
[TBL] [Abstract][Full Text] [Related]
20. FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors.
Kiyota M; Kuroda J; Yamamoto-Sugitani M; Shimura Y; Nakayama R; Nagoshi H; Mizutani S; Chinen Y; Sasaki N; Sakamoto N; Kobayashi T; Matsumoto Y; Horiike S; Taniwaki M
Apoptosis; 2013 Nov; 18(11):1437-1446. PubMed ID: 23851982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]